| Cash Flow | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Revenues | 336,595 | 1,448,685 | NaN | NaN |
| Employee expenses (excluding share-based compensation expense) | 81,019 | 309,600 | NaN | NaN |
| Share-based compensation expense | 1,861 | 13,850 | NaN | NaN |
| Other segment items | 229,292 | 1,028,812 | NaN | NaN |
| Depreciation and amortization | 5,976 | 22,335 | NaN | NaN |
| Interest expense | 154 | 665 | NaN | NaN |
| Income taxes | 4,749 | 24,465 | NaN | NaN |
| Net income | 13,544 | 21,265 | 9,593 | 18,100 |
| Depreciation and amortization | 5,976 | 5,741 | 5,838 | 10,756 |
| Share-based compensation expense | 1,861 | 1,080 | 4,356 | 8,414 |
| Provision for losses on accounts receivable | 1,062 | 1,471 | 1,206 | 1,904 |
| Change in deferred tax asset | NaN | 2,364 | 710 | NaN |
| Other | 79 | -490 | -155 | -430 |
| Accounts receivable | 11,129 | -3,040 | 13,180 | -1,587 |
| Inventories | 3,800 | -4,792 | 3,193 | 2,476 |
| Other current assets | 1,394 | 3,340 | -4,600 | 3,742 |
| Accounts payable | -7,797 | -4,750 | 17,397 | 3,751 |
| Accrued compensation | -2,258 | -896 | -1,350 | 2,864 |
| Other operating liabilities | 10,076 | 3,343 | 2,037 | -4,102 |
| Payment for acquisitions | NaN | 495 | 4,001 | 8,920 |
| Net cash provided by operating activities | 6,062 | 34,600 | 28,169 | 37,486 |
| Purchases of property and equipment | 5,019 | 4,227 | 5,207 | 10,111 |
| Proceeds from disposition of equipment | 269 | NaN | NaN | NaN |
| Other | 0 | 12 | 242 | 482 |
| Net cash used in investing activities | -4,750 | -4,710 | -8,966 | -18,549 |
| Proceeds from equity offering, net of underwriter fees | 30,276 | 0 | 0 | 29,039 |
| Repurchase (payments) of common stock | 30,276 | 0 | 29,039 | NaN |
| Payments of equity offering costs | 0 | 0 | 0 | 1,594 |
| Repurchase (payments) of common stock-Common Class B | NaN | 0 | NaN | NaN |
| Borrowings from notes payable | NaN | 0 | NaN | NaN |
| Repayment of notes payable | NaN | 0 | 497 | NaN |
| Repurchase of outstanding classa common stock | NaN | NaN | NaN | 29,039 |
| Borrowings from line of credit | NaN | 0 | NaN | NaN |
| Contingent payments related to acquisitions | NaN | NaN | 309 | 1,950 |
| Repayments of line of credit | NaN | 0 | NaN | NaN |
| Principal payments on finance lease obligations | 1,117 | 1,090 | 1,117 | 2,276 |
| Payments related to acquisitions | NaN | 2,509 | NaN | NaN |
| Contributions fromnon-controllinginterests | 79 | 351 | 390 | 1,229 |
| Distributions tonon-controllinginterests | 960 | 269 | 0 | 189 |
| Member distributions | NaN | 0 | NaN | NaN |
| Other | 40 | -500 | NaN | NaN |
| Net cash used in financing activities | -2,038 | -758 | -1,533 | -4,780 |
| Net change in cash and cash equivalents | -726 | 29,132 | 17,670 | 14,157 |
| Cash and cash equivalents, beginning of period | 65,619 | 36,487 | 4,660 | NaN |
| Cash and cash equivalents, end of period | 64,893 | 65,619 | 36,487 | NaN |
Guardian Pharmacy Services, Inc. (GRDN)
Guardian Pharmacy Services, Inc. (GRDN)